Angiotensin-converting enzyme inhibitors
N. J. Brown and D. E. Vaughan

Interaction of genetic deficiency of endothelial nitric oxide, gender, and pregnancy in vascular response to injury in mice
M. Moroi and others

Acute anti-ischemic effects of perindoprilat in men with coronary artery disease and their relation with left ventricular function
G. L. Bartels and others

Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators
S. Yusuf and others

Randomised trial of perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack
PROGRESS Collaborative Group

Perindopril alters vascular angiotensin-converting enzyme, AT1 receptor, and nitric oxide synthase expression in patients with coronary heart disease
J. L. Zhuo and others

Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint Reduction in hypertension study (LIFE): a randomized trial against atenolol
L. H. Lindholm and others

Effects of losartan and captopril on mortality and morbidity in high-risk patients after acute myocardial infarction: the OPTIMAAL randomized trial. Optimal Trial in Myocardial Infarction with Angiotensin II Antagonist Losartan
K. Dickstein and J. Kjekshus

Effects of candesartan on mortality and morbidity in patients with chronic heart failure: the CHARM Investigators and Committees
M. A. Pfeffer and others

Efficacy of perindopril in reduction of cardiovascular events among patients with stable coronary artery disease: randomized, double-blind, placebo-controlled, multicenter trial (the EUROPA study)
K. M. Fox; EUROPA Investigators